KANJINTI
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 30 Dec 2025)
What this means for you
Registered since 08 Oct 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87155764
- Registration number
- 5880416
- Mark type
- Stylized text
- Filed
- 30 Aug 2016
- Published for opposition
- 17 Jan 2017
- Registered
- 08 Oct 2019
- Attorney of record
- Elsa D. Lemoine
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations, namely, biosimilars used for the treatment of cancer; pharmaceutical preparations and biosimilars used for the treatment of breast and gastric disorders and diseases
Owner
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 30 Dec 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 Dec 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Dec 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Sept 2025 — TEAS SECTION 8 & 15 RECEIVED
- 25 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Feb 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 08 Oct 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 Oct 2019 — REGISTERED-PRINCIPAL REGISTER
- 04 Sept 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Sept 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Sept 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Aug 2019 — USE AMENDMENT FILED